Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 6
2003 6
2004 2
2005 11
2006 9
2007 10
2008 12
2009 10
2010 8
2011 10
2012 8
2013 18
2014 22
2015 17
2016 25
2017 24
2018 31
2019 24
2020 51
2021 23
2022 15
2023 15
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Results by year

Filters applied: . Clear all
Page 1
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.
Rachedi NS, Tang Y, Tai YY, Zhao J, Chauvet C, Grynblat J, Akoumia KKF, Estephan L, Torrino S, Sbai C, Ait-Mouffok A, Latoche JD, Al Aaraj Y, Brau F, Abélanet S, Clavel S, Zhang Y, Guillermier C, Kumar NVG, Tavakoli S, Mercier O, Risbano MG, Yao ZK, Yang G, Ouerfelli O, Lewis JS, Montani D, Humbert M, Steinhauser ML, Anderson CJ, Oldham WM, Perros F, Bertero T, Chan SY. Rachedi NS, et al. Among authors: lewis js. Cell Metab. 2024 Apr 24:S1550-4131(24)00130-X. doi: 10.1016/j.cmet.2024.04.010. Online ahead of print. Cell Metab. 2024. PMID: 38701775
NaV1.7 targeted fluorescence imaging agents for nerve identification during intraoperative procedures.
Gonzales J, Adilbay D, de Souza Franca PD, Artschwager R, Chow CY, Viray T, Johnson DS, Jiang Y, Patel SG, Ganly I, Schroeder CI, Lewis JS, King GF, Reiner T, Pillarsetty N. Gonzales J, et al. Among authors: lewis js. bioRxiv [Preprint]. 2024 Apr 6:2024.04.06.588368. doi: 10.1101/2024.04.06.588368. bioRxiv. 2024. PMID: 38617358 Free PMC article. Preprint.
18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, Gu P, Ku GY, Chou JF, Capanu M, Antoine A, Loegel D, Feder L, Philemond S, Lyashchenko SK, Lewis JS, Paroder V, Srivastava A, Tang LH, Schoder H, Janjigian YY. Cytryn SL, et al. Among authors: lewis js. J Nucl Med. 2024 May 1;65(5):722-727. doi: 10.2967/jnumed.123.267186. J Nucl Med. 2024. PMID: 38514081
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
Yeh R, O'Donoghue JA, Jayaprakasam VS, Mauguen A, Min R, Park S, Brockway JP, Bromberg JF, Zhi WI, Robson ME, Sanford R, Modi S, Agnew BJ, Lyashchenko SK, Lewis JS, Ulaner GA, Zeglis BM. Yeh R, et al. Among authors: lewis js. J Nucl Med. 2024 Mar 1;65(3):386-393. doi: 10.2967/jnumed.123.266392. J Nucl Med. 2024. PMID: 38272704 Free PMC article.
First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.
Tendler S, Dunphy MP, Agee M, O'Donoghue J, Aly RG, Choudhury NJ, Kesner A, Kirov A, Mauguen A, Baine MK, Schoder H, Weber WA, Rekhtman N, Lyashchenko SK, Bodei L, Morris MJ, Lewis JS, Rudin CM, Poirier JT. Tendler S, et al. Among authors: lewis js. medRxiv [Preprint]. 2024 Jan 11:2024.01.10.24301109. doi: 10.1101/2024.01.10.24301109. medRxiv. 2024. PMID: 38260492 Free PMC article. Preprint.
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model".
Ahad A, Saeed HK, Del Solar V, López-Hernández JE, Michel A, Mathew J, Lewis JS, Contel M. Ahad A, et al. Among authors: lewis js. ACS Pharmacol Transl Sci. 2024 Jan 3;7(1):298-299. doi: 10.1021/acsptsci.3c00364. eCollection 2024 Jan 12. ACS Pharmacol Transl Sci. 2024. PMID: 38230288 Free article.
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model.
Ahad A, K Saeed H, Del Solar V, López-Hernández JE, Michel A, Mathew J, Lewis JS, Contel M. Ahad A, et al. Among authors: lewis js. ACS Pharmacol Transl Sci. 2023 Nov 22;6(12):1972-1986. doi: 10.1021/acsptsci.3c00270. eCollection 2023 Dec 8. ACS Pharmacol Transl Sci. 2023. PMID: 38093840
319 results